U.S. market Closed. Opens in 16 hours 49 minutes

BDSX | Biodesix, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue49.09M38.21M54.51M45.56M24.55M20.43M
Cost of Revenue15.88M14.15M30.52M22.00M6.07M4.41M
Gross Profit33.21M24.06M23.99M23.56M18.48M16.03M
Operating Expenses74.51M74.56M63.31M45.67M41.10M34.09M
Selling, General & Admin64.52M61.46M50.52M34.86M30.64M25.90M
Research & Development9.99M13.10M12.79M10.82M10.47M8.19M
Other Operating Expenses6.00K109.00K-9.00K422.00K-2.38M-1.24M
Operating Income-41.30M-50.51M-39.32M-22.12M-22.63M-23.46M
Other Expenses / Income-10.85M-14.94M-3.84M-9.23M-8.10M-5.21M
Before Tax Income-52.15M-65.45M-43.16M-31.35M-30.73M-26.17M
Income Tax Expenses5.34M14.94M1.32M5.12M629.00K211.00K
Net Income-52.15M-80.39M-44.48M-36.47M-31.36M-26.17M
Interest Expenses9.54M8.07M4.51M7.60M3.01M2.92M
Basic Shares Outstanding82.11M42.10M27.36M26.56M254.92K26.13M
Diluted Shares Outstanding82.11M42.10M27.36M26.56M254.92K26.13M
EBITDA-35.79M-50.40M-39.33M-21.68M-22.16M-17.53M
EBITDA Margin-72.91%-131.89%-72.15%-47.58%-90.25%-85.81%
EBIT-37.27M-57.38M-38.65M-23.75M-27.72M-23.04M
EBIT Margin-75.93%-150.15%-70.91%-52.12%-112.90%-112.76%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙